屏障的性质决定了异质介质中的第一通道时间
Moumita Dasgupta1, Sougata Guha2,3, Leon Armbruster1
1Department of Physics, Augsburg University, MN 55454, USA. dasgupta@augsburg.edu.
Soft matter
|September 25, 2024
概括
与直觉相反,跨越障碍物的通行时间可以在更有活力的障碍物下降. 这项研究探讨了屏障类型 (能量与热带) 如何影响运输,并通过机器人实验和模拟验证了这些发现.
科学领域:
- 物理 物理学 物理
- 统计力学 统计力学
- 复杂的系统复杂的系统.
背景情况:
- 交通现象通常被认为随着越来越多的障碍物而放缓.
- 障碍物的性质 (能量与热带) 可以显著影响运输动态.
研究的目的:
- 为了研究屏障性质对d维度首次穿越时间的影响.
- 为了确定通行时间是否会随着障碍物数量的增加而单调增加.
- 探索在异质环境中有效扩散的行为.
主要方法:
- 精确的分析解决方案的第一个通道时间在d维度.
- 模拟扩散式和超扩散式运输.
- 在异质环境中使用机器人bug进行实验验证.
- 数字模拟. 数字模拟. 数字模拟. 数字模拟.
主要成果:
- 第一个通道时间表现出与能量障碍的非单调行为,随着障碍数量的增加而减少.
- 的障碍导致单调地增加通道时间.
- 有效的扩散性也显示出对能量障碍的非单调依赖.
- 非单调性是强大的,延伸到超扩散传输.
结论:
- 障碍数和通行时间之间的直观关系不适用于能量障碍.
- 屏障特性决定了异质介质中的运输特征.
- 实验和模拟结果证实了对非单调运输行为的理论预测.
相关概念视频
Factors Affecting Drug Distribution: Physiological Barriers
181
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
181
Viscosity
5.8K
When water is poured into a glass, it falls freely and quickly, whereas if honey or maple syrup is poured over a pancake, it flows slowly and sticks to the surface of the container. This difference in the flow of different kinds of liquids arises due to the fluid friction between the liquid layers and the liquid and the surrounding material. This property of fluids is called fluid viscosity. In this example, water has a lower viscosity than honey and maple syrup.
The SI unit of viscosity is...
The SI unit of viscosity is...
5.8K
Boundary Layer Characteristics
58
When a fluid encounters a solid surface, a boundary layer forms due to the interaction between the fluid's motion and the stationary surface. This phenomenon is characterized by a thin region adjacent to the surface where viscous forces dominate, influencing the fluid's velocity profile. The development of the boundary layer begins at the leading edge of the surface and evolves as the fluid moves downstream.As the fluid flows over the surface, friction between the fluid and the wall slows down...
58
General Characteristics of Pipe Flow II
882
When fluid enters a pipe, it first passes through the entrance region, where the velocity profile adjusts due to viscous effects. In this region, a boundary layer forms along the pipe walls and grows until it fully occupies the pipe's cross-section. Once the boundary layer merges, the flow becomes fully developed, with a steady velocity profile that remains consistent along the pipe's length.
The distance to reach a fully developed flow is called the entrance length and depends on the...
The distance to reach a fully developed flow is called the entrance length and depends on the...
882
Passive Diffusion: Overview and Kinetics
428
Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
428
Factors Influencing Bioavailability: First-Pass Elimination
6.2K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.2K


